Zobrazeno 1 - 10
of 31
pro vyhledávání: '"PRIYADHARSINI, Rajendran"'
Autor:
Rekha Priyadarshini, Madhavi Eerike, Sakthivadivel Varatharajan, Gomathi Ramaswamy, Gerard Marshall Raj, Jerin Jose Cherian, Priyadharsini Rajendran, Venugopalan Gunasekaran, Shailaja V Rao, Venu Gopala Rao Konda
Publikováno v:
JMIR Research Protocols, Vol 13, p e55638 (2024)
BackgroundFalls in older patients can lead to serious health complications and increased health care costs. Fall risk–increasing drugs (FRIDs) are a group of drugs that may induce falls or increase the tendency to fall (ie, fall risk). Deprescribin
Externí odkaz:
https://doaj.org/article/549a48cc137f4169906741560fd35d57
Publikováno v:
Journal of Pharmacy and Bioallied Sciences, Vol 14, Iss 3, Pp 162-167 (2022)
Background and Objective: Inadequate knowledge and underreporting of medical device-associated adverse events (MDAEs) were observed among health-care professionals (HCPs) in studies carried out in other countries. In India, HCP's knowledge, attitude,
Externí odkaz:
https://doaj.org/article/2f7d72944fdc41b286aa3beb8f2e18a9
Publikováno v:
Perspectives in Clinical Research, Vol 12, Iss 3, Pp 118-125 (2021)
The “National Guidelines for Gene Therapy Product (GTP) Development and Clinical Trials” prepared by the Indian Council of Medical Research and Department of Biotechnology in 2019 came as a welcome step in the process of regulation of gene therap
Externí odkaz:
https://doaj.org/article/1da7ab28aae54dc4bb1dd18d36ecfde9
Publikováno v:
Drug Metabolism and Personalized Therapy.
Objectives Carbamazepine (CBZ) is a first-line antiseizure drug used for focal onset seizures. It exhibits inter-individual variability in plasma carbamazepine levels and there are both genetic and non-genetic factors having a role in the requirement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95b97e3f38af7e494deb7d6a0cbb09e8
https://doi.org/10.1515/dmpt-2022-0157
https://doi.org/10.1515/dmpt-2022-0157
Publikováno v:
GLOBAL JOURNAL OF MEDICAL STUDENTS. :15-20
Background: Diabetes mellitus is one of the leading causes of mortality and morbidity throughout the world. Despite India being the diabetes capital of the world with a high prevalence even in rural regions, pharmacotherapy of diabetes is not uniform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::068875dfdbe1de9121a681069cfe70d2
https://doi.org/10.52314/gjms.2022.v2i2.68
https://doi.org/10.52314/gjms.2022.v2i2.68
Publikováno v:
Perspectives in Clinical Research, Vol 12, Iss 3, Pp 118-125 (2021)
Perspectives in Clinical Research
Perspectives in Clinical Research
The “National Guidelines for Gene Therapy Product (GTP) Development and Clinical Trials” prepared by the Indian Council of Medical Research and Department of Biotechnology in 2019 came as a welcome step in the process of regulation of gene therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c47d9fba2f52f31aa001314957ab4660
http://www.picronline.org/article.asp?issn=2229-3485
http://www.picronline.org/article.asp?issn=2229-3485
Autor:
Reka Deva, Priyadharsini Rajendran
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 11:520
Every 5 minutes, someone somewhere in the world is diagnosed with an inflammatory, demyelinating, neurodegenerative disorder known as multiple sclerosis (MS). MS was historically known as "La sclèrose en plaques" which involves the central nervous s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4244fce2b7793890f0908cbc03499b62
https://doi.org/10.18203/2319-2003.ijbcp20221826
https://doi.org/10.18203/2319-2003.ijbcp20221826
Autor:
Sandhiya Selvarajan, Mahalakshmi Ganesapandian, Priyadharsini Rajendran, Kiruthika Sivagourounadin
Publikováno v:
Current drug safety. 17(1)
Background and Objective: Identification of the offending drug is crucial and challenging in cases of severe cutaneous adverse drug reactions (CADR) like Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Poor reproducibility and va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a20f04d0325b4f1521740bbb1e5df2
https://pubmed.ncbi.nlm.nih.gov/34126908
https://pubmed.ncbi.nlm.nih.gov/34126908
Autor:
GAURANG, Narayan, PRIYADHARSINI, Rajendran, BALAMURUGESAN, Kandan, PRAKASH, Mathiyalagen, REKA, Devanathan
Publikováno v:
Pharmacy Practice (1886-3655); Jul-Sep2021, Vol. 19 Issue 3, p1-9, 9p
Autor:
Priyadharsini Rajendran, Geetha Krishnasamy, Vijayalakshmi Subbiah, Kiruthika Sivagourounadin
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 9:282
BACKGROUND: The occurrence of metabolic abnormalities in schizophrenic patients has been increasing with the use of second generation antipsychotics. AIM AND OBJECTIVE: To compare the metabolic derangements induced by one of the typical antipsychotic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fe42341c3cc042eab4b57ed40cf07ab
https://doi.org/10.18203/2319-2003.ijbcp20200177
https://doi.org/10.18203/2319-2003.ijbcp20200177